High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants (HIDVID Trial): Study Protocol for a Randomized Controlled Study

High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants (HIDVID Trial): Study Protocol for a Randomized Controlled Study

Vitamin D deficiency can escalate prematurity bone disease in preterm infants and negatively influence their immature immunology system. Infants born at 24 + 0/7 weeks to 32 + 6/7 weeks of gestation will be considered for inclusion. Cord or vein blood samples will be obtained within 48 h after birth...

Full description

Bibliographic Details
Main Authors: Dominika Paw, Renata Bokiniec, Alicja Kołodziejczyk-Nowotarska
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Nutrients
Subjects:
vitamin D
infant
premature
osteopenia
sepsis
interleukin-6
Online Access:https://www.mdpi.com/2072-6643/16/5/700

Internet

https://www.mdpi.com/2072-6643/16/5/700

Similar Items